Oncology Central

Prognostic biomarkers in squamous cell carcinoma of the head and neck


Personalized management of cancer involves evaluating the complex interplay of unique markers to determine the optimal treatment approach for each patient. Prognostic factors can be divided into two general categories, patient- and tumor-specific factors. Each of these categories has implications for how we approach patients.

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.